2026 Nobel Prize in Medicine awarded to Deisseroth, Hegemann and Nagel for optogenetics

The announcement

On 5 October 2026, the Nobel Assembly at Karolinska Institutet awarded the 2026 Nobel Prize in Physiology or Medicine jointly to Karl Deisseroth, Peter Hegemann and Georg Nagel, with each laureate taking an equal one-third share of the prize. According to the citation published on the Nobel Prize website, the three are recognised "for their discoveries concerning light-gated ion channels and optogenetics."

The medicine prize opens this year's Nobel week. The Nobel Prize organization says the remaining categories will be announced between 5 and 12 October, with all announcements streamed live on its website.

From an algal protein to a neural switch

The award recognises two connected steps. According to the Nobel Assembly, Hegemann and Nagel discovered channelrhodopsin, a protein with an unusual property: whichever kind of cell the researchers placed it in, that cell became responsive to light. The popular-science material published alongside the prize frames the finding as the story of a light-sensitive protein from algae that went on to energise neuroscience.

Deisseroth carried the discovery into the brain. The Nobel Assembly credits him with introducing the gene for channelrhodopsin into nerve cells from rats and showing that illuminating those cells with blue light was enough to trigger a nerve signal. He later extended the technique so that the same light-controlled switch worked in the brains of living mice.

The method that came out of this work — controlling nerve signals with light — is now known as optogenetics. The accompanying scientific background presents it as the discovery of a switch for neurons.

What the technique enables

The Nobel Prize materials describe optogenetics as an answer to one of neuroscience's longest-standing ambitions: understanding how the brain produces memories, feelings and behaviours. Because researchers can now switch the activity of individual nerve cells in a living brain on or off, they can run causal experiments rather than merely observing which patterns of activity happen to accompany a behaviour.

According to the Nobel Prize organization, the method spread rapidly after its introduction and is now in daily use in laboratories around the world, which is a central reason the work was honoured: it did not simply answer a question, it changed the questions neuroscientists are able to ask.

Why it matters

For readers outside biology, the significance is easy to state. Machine learning took its founding vocabulary — neurons, networks, learning — from the brain, yet biological circuits are still understood only in outline. A tool that lets an experimenter stimulate or silence chosen cells in a living animal generates ground truth about what networks of neurons actually compute, evidence that no amount of modelling can substitute for.

That makes this year's medicine prize relevant well beyond medicine. Work built on optogenetics is helping map how real neural circuits give rise to behaviour, and those findings feed back into how both neuroscientists and AI researchers reason about what networks of neurons can and cannot do.